Cargando…

The impact of pre-transplantation nephrectomy on quality of life in patients with autosomal dominant polycystic kidney disease

PURPOSE: In selected ADPKD patients, a nephrectomy is required in the work-up for a kidney transplantation. Because the impact of this procedure is unknown, we investigated the effect of pre-transplantation nephrectomy on quality of life in this group. METHODS: In this retrospective cohort study all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geertsema, Paul, Gansevoort, Ron T., Brenkman, Lisanne P. J., Dekker, Shosha E. I., Eleveld, Damia V. P., de Fijter, Johan W., Leliveld, Anna M., Levy, Maya, Meijer, Esther, Pol, Robert A., Schillern, Emmelien E. M., Sanders, Jan-Stephan F., Casteleijn, Niek F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160200/ https://www.ncbi.nlm.nih.gov/pubmed/36930253 http://dx.doi.org/10.1007/s00345-023-04349-4

Ejemplares similares

The Need for Routine Native Nephrectomy in the Workup for Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease Patients
por: Casteleijn, Niek F., et al.
Publicado: (2023)

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019)

Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease
por: van Luijk, Franka, et al.
Publicado: (2022)

Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A Patient with Exceptionally Large, Still Functioning Kidneys
por: Spithoven, Edwin M., et al.
Publicado: (2014)

The Presence of Kidney Cyst Infections in Patients With ADPKD After Kidney Transplantation: Need for Urological Analysis?
por: Geertsema, Paul, et al.
Publicado: (2022)

Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial
por: Casteleijn, Niek F., et al.
Publicado: (2016)

Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
por: Dekker, Shosha E. I., et al.
Publicado: (2020)

Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression
por: Messchendorp, A. Lianne, et al.
Publicado: (2017)

Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study
por: Lantinga, Marten A., et al.
Publicado: (2016)

Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease
por: Messchendorp, A. Lianne, et al.
Publicado: (2018)

Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease
por: Bais, Thomas, et al.
Publicado: (2022)

Transperitoneal Laparoscopic Nephrectomy for Autosomal Dominant Polycystic Kidney Disease
por: Verhoest, Grégory, et al.
Publicado: (2012)

Introduction of laparoscopic nephrectomy for autosomal dominant polycystic kidney disease as the standard procedure
por: Thomas, M. N., et al.
Publicado: (2023)

Predictors and outcomes of laparoscopic nephrectomy in autosomal dominant polycystic kidney disease
por: Chen, Kenneth, et al.
Publicado: (2018)

Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review
por: Natale, Patrizia, et al.
Publicado: (2021)

Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients
por: Heida, Judith E., et al.
Publicado: (2021)

Native Nephrectomy in Renal Transplant Recipients With Autosomal-Dominant Polycystic Kidney Disease
por: Chebib, Fouad T., et al.
Publicado: (2015)

Retroperitoneoscopic nephrectomy for huge autosomal-dominant polycystic kidney disease using morcellator
por: Lee, Dong Sup, et al.
Publicado: (2018)

Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease
por: El-Damanawi, Ragada, et al.
Publicado: (2021)

Simultaneous Native Nephrectomy and Kidney Transplantation in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Veroux, Massimiliano, et al.
Publicado: (2016)

Thiazide diuretics and the rate of disease progression in autosomal dominant polycystic kidney disease: an observational study
por: Kramers, Bart J, et al.
Publicado: (2020)

Laparoscopic Nephrectomy versus Open Nephrectomy for Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis
por: Guo, Pengyu, et al.
Publicado: (2015)

Simultaneous kidney transplantation and ipsilateral native nephrectomy in patients with autosomal dominant polycystic kidney disease
por: Gadelkareem, Rabea Ahmed, et al.
Publicado: (2022)

Native Nephrectomy before and after Renal Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Maxeiner, Andreas, et al.
Publicado: (2019)

Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series
por: Bernts, Lucas H P, et al.
Publicado: (2020)

Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report
por: Natale, Patrizia, et al.
Publicado: (2021)

Serum bicarbonate is associated with kidney outcomes in autosomal dominant polycystic kidney disease
por: Blijdorp, Charles J, et al.
Publicado: (2020)

Pretransplant Nephrectomy for Large Polycystic Kidneys in ADPKD (Autosomal Dominant Polycystic Kidney Disease) Patients: Is Peritoneal Dialysis Recovery Possible after Surgery?
por: Ietto, Giuseppe, et al.
Publicado: (2019)

Feasibility of measuring renal blood flow by phase-contrast magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease
por: Spithoven, E. M., et al.
Publicado: (2015)

Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)
por: Burgmaier, Kathrin, et al.
Publicado: (2020)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Safety and feasibility of synchronous unilateral nephrectomy and contralateral heminephrectomy for extremely severe autosomal dominant polycystic kidney disease: Techniques and outcome
por: Han, Jang Hee, et al.
Publicado: (2022)

Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor–Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients
por: Dekker, Shosha E.I., et al.
Publicado: (2019)

The association of glucagon with disease severity and progression in patients with autosomal dominant polycystic kidney disease: an observational cohort study
por: Knol, Martine G E, et al.
Publicado: (2021)

Simultaneous right-sided nephrectomy with orthotopic liver and kidney transplantation—An alternative method for patients with autosomal dominant polycystic liver and kidney disease
por: Felgendreff, Philipp, et al.
Publicado: (2021)

Autosomal Recessive Polycystic Kidney Disease
por: Salati, Sajad Ahmad
Publicado: (2014)

Autosomal Recessive Polycystic Kidney Disease
por: Hafer, Ashley S., et al.
Publicado: (2017)

Autosomal dominant and autosomal recessive polycystic kidney disease: hypertension and secondary cardiovascular effect in children
por: Lucchetti, L., et al.
Publicado: (2023)

Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease
por: Grantham, Jared J., et al.
Publicado: (2017)

Autosomal recessive polycystic kidney disease diagnosed in fetus
por: Thomas, Joseph, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_qog1rapkl6slsr1d5boqll40c2